Gefitinib for refractory advanced non-small-cell lung cancer.
Tsurutani
Junji
J
Ballas
Marc
M
Steinberg
Seth M
SM
Egilsson
Valgardur
V
Dennis
Phillip A
PA
D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000069347:Erlotinib Hydrochloride; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012907:Smoking / Q000009:adverse effects*
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib